comparemela.com

Latest Breaking News On - Applied dna sciences inc - Page 1 : comparemela.com

Analysts New Coverage for April 29th (AAON, ABVX, AMPE, APDN, BKSC, BLIN, BYFC, CMCT, CPE, CVLY)

Analysts’ new coverage for Monday, April 29th: William Blair initiated coverage on shares of AAON (NASDAQ:AAON). They issued an outperform rating on the stock. Guggenheim began coverage on shares of ABIVAX Société Anonyme (NASDAQ:ABVX). They issued a buy rating and a $50.00 target price on the stock. Piper Sandler began coverage on shares of ABIVAX […]

Analysts New Coverage for December 23rd (AGLE, AINC, ALIM, APDN, BKCC, BKSC, BLIN, BYFC, CASI, CBFV)

Analysts’ new coverage for Saturday, December 23rd: StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Ashford (NYSEAMERICAN:AINC). They issued a buy rating on the stock. StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM). StockNews.com issued a hold rating on […]

Applied DNA Sciences, Inc (NASDAQ:APDN) Q4 2023 Earnings Call Transcript

Operator: Good Day and welcome to the Applied DNA Sciences Fiscal Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

Investment Analysts New Coverage for September 2nd (AMOT, APDN, AVID, BLIN, BWA, BYFC, CASI, CBD, CGIX, CLLS)

Investment Analysts’ new coverage for Saturday, September 2nd: StockNews.com initiated coverage on shares of Allied Motion Technologies (NASDAQ:AMOT). They issued a buy rating on the stock. StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN). The firm issued a hold rating on the stock. StockNews.com began coverage on shares of Avid Technology (NASDAQ:AVID). StockNews.com […]

Research Analysts New Coverage for June 14th (ADC, AGLE, AJRD, APDN, BLIN, BRAG, BSET, BSY, BYFC, CARV)

Research Analysts’ new coverage for Wednesday, June 14th: BNP Paribas began coverage on shares of Agree Realty (NYSE:ADC). The firm issued an outperform rating and a $80.00 target price on the stock. StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). The firm issued a hold rating on the stock. StockNews.com assumed coverage on shares […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.